[HTML][HTML] Local delivery and glioblastoma: why not combining sustained release and targeting?

C Gazaille, M Sicot, P Saulnier, J Eyer… - Frontiers in Medical …, 2021 - frontiersin.org
Glioblastoma is one of the most aggressive brain tumors and is associated with a very low
overall median survival despite the current treatment. The standard of care used in clinic is …

Local Delivery and Glioblastoma: Why Not Combining Sustained Release and Targeting?

C Gazaille, M Sicot, P Saulnier, J Eyer… - Frontiers in Medical …, 2021 - europepmc.org
Glioblastoma is one of the most aggressive brain tumors and is associated with a very low
overall median survival despite the current treatment. The standard of care used in clinic is …

Local Delivery and Glioblastoma: Why Not Combining Sustained Release and Targeting?

C Gazaille, M Sicot, P Saulnier… - Frontiers in medical …, 2021 - pubmed.ncbi.nlm.nih.gov
Glioblastoma is one of the most aggressive brain tumors and is associated with a very low
overall median survival despite the current treatment. The standard of care used in clinic is …

[HTML][HTML] Local Delivery and Glioblastoma: Why Not Combining Sustained Release and Targeting?

C Gazaille, M Sicot, P Saulnier, J Eyer… - Frontiers in Medical …, 2021 - ncbi.nlm.nih.gov
Glioblastoma is one of the most aggressive brain tumors and is associated with a very low
overall median survival despite the current treatment. The standard of care used in clinic is …